PlainRecalls
FDA Drug Moderate Class II Terminated

Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03

Reported: January 15, 2025 Initiated: December 18, 2024 #D-0187-2025

Product Description

Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03

Reason for Recall

Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.

Details

Units Affected
96 Bottles
Distribution
Nationwide within the United States
Location
Chantilly, VA

Frequently Asked Questions

What product was recalled?
Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03. Recalled by Granules Pharmaceuticals Inc.. Units affected: 96 Bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 15, 2025. Severity: Moderate. Recall number: D-0187-2025.